Wall Street Journal - May 28
May 28 (Reuters) -The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
- Swedish specialty pharmaceutical company Calliditas Therapeutics CALTX.ST received a $1.1 billion takeover bid from Japan's Asahi Kasei 3407.T.
- ABN AMRO Bank ABNd.AS has agreed to acquire Hauck Aufhauser Lampe, a private bank in Germany for 672 million euros ($730.33 million) from Chinese conglomerate Fosun International 0656.HK.
- Elon Musk's xAI said it raised $6 billion in its latest fundraising round, as the OpenAI rival looks to invest more in research and development amid fierce competition in the burgeoning sector.
- The Japanese automaker Toyota 7203.T Motor plans to develop new engines that run on carbon-neutral fuels and are fit for electrification as part of efforts by the world's largest carmaker to cut carbon emissions and save jobs at engine-part suppliers.
($1 = 0.9201 euros)
(Compiled by Bengaluru newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
